Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/1998
05/28/1998CA2268041A1 Xanthines and their therapeutic use
05/28/1998CA2268037A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998CA2266659A1 Pretreatment with growth factors to protect against cns damage
05/28/1998CA2256694A1 Combinatorial synthesis of carbohydrate libraries
05/27/1998EP0844002A1 Use of activated hemicellulose for the induction of interleukin-12
05/27/1998EP0843999A1 Use of estrogen agonists/antagonists for the manufacture of a medicament in the treatment of atherosclerosis independent of a lipid lowering effect
05/27/1998EP0843681A1 Heterocycle-fused thiazole derivatives
05/27/1998EP0843679A1 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
05/27/1998EP0843674A1 Lubeluzole n-oxide
05/27/1998EP0843671A1 Heterocyclic compounds and pharmaceutical compositions containing them
05/27/1998EP0843661A1 (1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate
05/27/1998EP0843583A1 Golf club receptacle
05/27/1998EP0843553A1 Use of pde inhibitors in the manufacture of a medicament for the treatment of bladder diseases
05/27/1998EP0843551A1 Endothelin receptor antagonists
05/27/1998EP0843550A1 Nitric oxide synthase (nos) inhibitors
05/27/1998EP0843549A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4? hydrolase inhibitor
05/27/1998EP0786253A4 Agent for suppressing tumour growth
05/27/1998EP0720551B1 Hydraulic system for anti-lock braking installations in motor vehicles
05/27/1998EP0664697B1 Ranitidine chewable tablets
05/27/1998EP0656889B1 9-chloroprostaglandin esters and amides and their use in the preparation of drugs
05/27/1998EP0587571B1 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN
05/27/1998CN1183117A Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies
05/27/1998CN1183103A Peptide compositions with growth factor-like activity
05/27/1998CN1183099A Pyrido (2, 3 -d) pyrimidines for inbibiting protein tyrosine kinase mediated cellular proliferation
05/27/1998CN1183045A Substances extracted from dictyotales, Preparation method therefor, and compositions containing same
05/27/1998CN1182746A Novel heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
05/27/1998CN1182737A New 2-(1H) -quinolinone compounds, process for preparing them and pharmaceutical compositions containing them
05/27/1998CN1182734A Imidaxolyl-substituted cyclohexane derivant
05/27/1998CN1182592A Stable prostaglandin E1-containing injectable composition
05/27/1998CN1182591A Improvement for prevention of mammary gland cancer or the prevention of mammary gland canner
05/27/1998CN1182590A Method for prevention of mammary gland cancer
05/27/1998CN1038511C Imidazopyridine and preparation process and its pharmaceutic usage
05/27/1998CN1038505C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
05/26/1998US5756832 Process for preparing amino acid esters useful as intermediates for compounds containing a fused bicyclic ring
05/26/1998US5756810 Process of preparing 3-nitro benzoate compounds in lower alkanol
05/26/1998US5756782 Suspending diacetylrhein in an organic solvent and water mixture, adding tertiary amine, then adding to the solution obtained, an caraboxylic acid salt of alkali or alkaline metals, hydrolyzing, collecting pure product by filtration
05/26/1998US5756764 Drug; proteasome inhibitors
05/26/1998US5756733 Vitamin D amide derivatives
05/26/1998US5756664 Genetic engineering of proteins with nucleotide sequences for bones
05/26/1998US5756535 Antiarrhythmia agents; antiischemic agents; cell antiproliferative agents
05/26/1998US5756533 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
05/26/1998US5756532 Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
05/26/1998US5756510 Potentiate effects of cytotoxic drugs or radiotherapy
05/26/1998US5756504 Tocolytic oxytocin receptor antagonists
05/26/1998US5756499 Substituted imidazole compounds
05/26/1998US5756496 Drugs for treating central nervous system disorder
05/26/1998US5756492 Graft survival prolongation with porphyrins
05/26/1998US5756489 18,19-dinor-vitamin D compounds
05/26/1998US5756485 Silicone-containing derivatives of salicylic acid which have desquamating properties
05/26/1998US5756467 Useful in prevention and therapy of obesity and cardiovascular diseases in humans and animals; administering in food and feeds
05/26/1998US5756466 Inhibitors of interleukin-1β converting enzyme
05/26/1998US5756465 Protease enzyme inhibitors
05/26/1998US5756463 Use of insulin and IGF-1
05/26/1998US5756462 Polypeptide isolated from venom of spider
05/26/1998US5756457 Neural regeneration using human bone morphogenetic proteins
05/26/1998US5756349 Culture of cells and radioimmunoassay
05/26/1998US5756329 DNA encoding phenylalanyl tRNA synthetase from Staphylococcus aureus
05/26/1998US5756320 Culturing microorganisms belonging to the genus streptomyces; isolation; exhibit inhibitory action on interleukin-6
05/26/1998US5756310 Culture product
05/26/1998US5756264 Expression vector systems and method of use
05/26/1998US5756090 Oxygen activatable formulations for disinfection or sterilization
05/26/1998US5756084 Human stromal derived factor 1α and 1β
05/26/1998US5755237 Intravenous injection
05/26/1998CA2136823C Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism
05/26/1998CA2052073C Sulfonamide fibrinogen receptor antagonists
05/25/1998CA2215929A1 Novel lep
05/22/1998WO1998021359A1 Glutathione s-transferase (gst) genes in cancer
05/22/1998WO1998021342A1 Nucleic acid sequences that encode a cell growth regulatory protein and uses thereof
05/22/1998WO1998021332A2 Secreted proteins and polynucleotides encoding them
05/22/1998WO1998021327A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences
05/22/1998WO1998021237A2 Peptide compounds useful for modulating fgf receptor activity
05/22/1998WO1998021232A2 Mutant forms of fas ligand and uses thereof
05/22/1998WO1998021228A1 Tissue specific expression of retinoblastoma protein
05/22/1998WO1998021222A2 1-galactose derivatives
05/22/1998WO1998021221A2 1-thiogalactose derivatives
05/22/1998WO1998021220A2 Saccharide derivatives
05/22/1998WO1998021209A1 New imidazopyridines and oxazolopyridines
05/22/1998WO1998021208A1 Benzonaphthyridines as bronchial therapeutics
05/22/1998WO1998021207A1 (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
05/22/1998WO1998021186A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
05/22/1998WO1998021184A1 Process for substituted pyridines
05/22/1998WO1998021183A1 Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments
05/22/1998WO1998021177A1 Benzenesulfonamide derivatives and drugs containing the same
05/22/1998WO1998020932A2 Conditioning for allogeneic stem cell transplantation
05/22/1998WO1998020892A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998WO1998020886A1 Pretraumatic use of hemoglobin
05/22/1998WO1998020885A1 Analogs of peptide yy and uses thereof
05/22/1998WO1998020875A1 5-ht1f agonists
05/22/1998CA2271788A1 Analogs of peptide yy and uses thereof
05/22/1998CA2271673A1 Benzenesulfonamide derivatives and drugs containing the same
05/22/1998CA2271464A1 Conditioning for allogeneic stem cell transplantation
05/22/1998CA2271272A1 5-ht1f agonists
05/22/1998CA2271116A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
05/22/1998CA2270910A1 Glutathione s-transferase (gst) genes in cancer
05/22/1998CA2270873A1 Secreted proteins and polynucleotides encoding them
05/22/1998CA2270871A1 Peptide compounds useful for modulating fgf receptor activity
05/22/1998CA2270766A1 Pretraumatic use of hemoglobin
05/22/1998CA2270629A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998CA2268018A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences
05/22/1998CA2263148A1 Nucleic acid sequences that encode a cell growth regulatory protein and uses thereof
1 ... 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 ... 1564